KANDUR
Hemostatic Scaffold Granule
To control bleeding, various pharmacological medications have been created. Nonetheless, it is essential that these substances affect scaffold, coagulation, vasoconstriction, and thrombin production. In addition to scaffold qualities, we wanted to show that the agents could halt bleeding on both minor and big open bleedings following skin clefts, extracorporal injuries, traumatic cuts, and spontaneous or surgical intervention. To investigate blood-stopping and scaffolding effects in a rat femoral bleeding model, a novel and genuine hemostatic substance, processed patented (PD), and the most popular chitosan in the medical field were utilized. Scanning electron microscopy (SEM) was used to analyze the samples, and the outcomes of blood stoppage were reported.
​
https://tjtes.org/jvi.aspx?pdir=travma&plng=eng&un=UTD-34359
Our Story
The owner of the patent is Ismail Altntop.
Emergency medicine is Ismail Altintop's area of expertise. He has practiced in emergency care at all levels since 2000. He has been using hemostatic drugs in emergency settings for many years. It has produced an agent that is better than the wound area and is natural and easy to clean. We are thrilled to present this new R&D team and blood stopper to you.
Meet The Team
Assoc. Prof. Dr. İsmail Altıntop In 2002, İsmail Altıntop started his residency at Erciyes University Faculty of Medicine, Department of Emergency Medicine, and became an Emergency Medicine Specialist in 2006. During his residency, he focused on disaster and emergency medicine, particularly earthquake medical response. Between 2007 and 2009, he worked as an Emergency Medicine Specialist and Emergency Department Supervisor at Kayseri Training and Research Hospital. He held managerial positions in private healthcare institutions. He completed his compulsory service at Diyarbakır State Hospital and fulfilled his military service at the Turkish General Staff between 2009 and 2010. After serving as the Emergency Department Supervisor at Niğde State Hospital, he returned to Kayseri Training and Research Hospital in 2012. In 2014, he completed the "Research Methodology in Healthcare" program, a joint initiative of Koç University and Harvard University. On June 1, 2018, he was appointed as the founding Chief Physician of Kayseri State Hospital, a position he continues to hold. In 2020, he became an Associate Professor of Emergency Medicine and continues his academic work as a faculty member at the University of Health Sciences.
Our Stakeholders
.jpg)
